Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

NCT00667888 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00667888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00667888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Unknown status
Start date
January 3, 2001
Completion date
October 31, 2021
Enrollment
225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer